Condition: Asthma · Sponsor: Chinese University of Hong Kong
The landscape of biologics therapy used in Hong Kong is currently unknown. The purpose of this study is to conduct a retrospective analysis of the use of biologics treatment for severe asthma in Hong Kong. The study aims to assess the landscape of biologics usage, evaluate the characteristics and conditions of patients before and after receiving biologic therapy, and provide insights into the effectiveness and safety of these treatments in the local population.
This description comes directly from the study's public registry record.
Fanny WS Ko, MD · 852 35053133 · fannyko@cuhk.edu.hk
David SC Hui, MD · 852 35053133 · dschui@cuhk.edu.hk
Always discuss trial participation with your own doctor first.
| Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, NT, HK | Hong Kong, Hong Kong | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06778746